glp 1 and restless leg syndrome Surprising Cause of the Legs (RLS) – HealthAid® Restless Legs Syndrome (RLS) &

Zepbound is a medication that blocks the absorption of certain types of fat in the digestive tract and may lead to weight loss in some people

47% of patients achieved more than 10% weight loss compared to 1% on placebo

Apply gentle pressure with a clean cotton swab do not rub, as this may affect absorption

For more information on Ros Body Membership and full suite of GLP-1 options, visit Ro.co/weightloss

Why These Results Are Meaningful A New Level of Weight Change The degree of weight reduction seen in TRIUMPH-4 exceeds that observed with many earlier investigational agents and has drawn attention within the metabolic health community

The unique action of retatrutide on GLP-1, GIP, and glucagon receptors suggests it could be effective in addressing multiple metabolic disorders